Symbol:
Cygb
Name:
cytoglobin
RGD ID:
69415
Description:
Enables heme binding activity; nitric oxide dioxygenase activity, heme protein as donor; and peroxidase activity. Involved in several processes, including negative regulation of collagen biosynthetic process; negative regulation of hepatic stellate cell activation; and nitric oxide catabolic process. Located in cytoplasm. Used to study liver cirrhosis and renal fibrosis. Biomarker of kidney disease and liver cirrhosis. Orthologous to human CYGB (cytoglobin); INTERACTS WITH (+)-schisandrin B; 17alpha-ethynylestradiol; 17beta-estradiol 3-benzoate.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
Glnf; globin f; HGb; histoglobin; MGC95105; nitric oxygen dioxygenase CYGB; nitrite reductase CYGB; pseudoperoxidase CYGB; Staap; Stap; stellate cell activation associated protein; stellate cell activation-associated protein; superoxide dismutase CYGB
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
CYGB (cytoglobin)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Cygb (cytoglobin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Cygb (cytoglobin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
CYGB (cytoglobin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
CYGB (cytoglobin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Cygb (cytoglobin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
CYGB (cytoglobin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
CYGB (cytoglobin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Cygb (cytoglobin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
CLDN1 (claudin 1)
HGNC
OMA
Alliance orthologs 3
Mus musculus (house mouse):
Cygb (cytoglobin)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
CYGB (cytoglobin)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cygb1 (cytoglobin 1)
Alliance
DIOPT (Ensembl Compara|Hieranoid|PANTHER|PhylomeDB)
Danio rerio (zebrafish):
cygb2 (cytoglobin 2)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
glb-14
Alliance
DIOPT (Ensembl Compara|InParanoid|OrthoFinder|OrthoInspector|PANTHER)
Caenorhabditis elegans (roundworm):
glb-34
Alliance
DIOPT (Ensembl Compara|InParanoid|OMA|OrthoFinder)
Drosophila melanogaster (fruit fly):
glob1
Alliance
DIOPT (Ensembl Compara|InParanoid|OrthoFinder|OrthoInspector)
Xenopus tropicalis (tropical clawed frog):
cygb
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 102,376,506 - 102,386,272 (-) NCBI GRCr8 mRatBN7.2 10 101,877,675 - 101,887,442 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 101,877,676 - 101,887,442 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 106,934,815 - 106,944,558 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 106,397,907 - 106,407,650 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 101,798,546 - 101,808,312 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 105,618,325 - 105,628,091 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 105,618,326 - 105,628,091 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 105,280,904 - 105,290,670 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 106,759,885 - 106,769,651 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 106,774,389 - 106,784,155 (-) NCBI Celera 10 100,448,536 - 100,458,302 (-) NCBI Celera Cytogenetic Map 10 q32.2 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Cygb Rat fundus dystrophy ISO RGD:1345183 8554872 ClinVar Annotator: match by term: Retinal dystrophy ClinVar PMID:16199547|PMID:16938425|PMID:20507925|PMID:23661369|PMID:23805042|PMID:25741868|PMID:26497376|PMID:26806561|PMID:28181551|PMID:28492532|PMID:29785639|PMID:31213501|PMID:31456290|PMID:31589614|PMID:31964843|PMID:34426522|PMID:36819107 Cygb Rat genetic disease ISO RGD:1345183 8554872 ClinVar Annotator: match by term: Inborn genetic diseases ClinVar PMID:28492532 Cygb Rat retinitis pigmentosa ISO RGD:1345183 8554872 ClinVar Annotator: match by term: Retinitis Pigmentosa, Recessive | ClinVar Annotator: match by term: Retinitis more ... ClinVar PMID:16938425|PMID:17576681|PMID:20507925|PMID:23661369|PMID:23805042|PMID:25741868|PMID:26806561|PMID:28181551|PMID:28492532|PMID:29785639|PMID:9536098 Cygb Rat retinitis pigmentosa ISO RGD:1345183 8554872 ClinVar Annotator: match by term: Retinitis Pigmentosa, Recessive | ClinVar Annotator: match by term: Retinitis more ... ClinVar PMID:16199547|PMID:16938425|PMID:17576681|PMID:20507925|PMID:23661369|PMID:23805042|PMID:25741868|PMID:26497376|PMID:26806561|PMID:28181551|PMID:28492532|PMID:29785639|PMID:31213501|PMID:31456290|PMID:31589614|PMID:31964843|PMID:32036094|PMID:34426522|PMID:36819107|PMID:36909829|PMID:9536098 Cygb Rat retinitis pigmentosa 36 ISO RGD:1345183 8554872 ClinVar Annotator: match by term: Retinitis pigmentosa 36 ClinVar PMID:16938425|PMID:20507925|PMID:23661369|PMID:23805042|PMID:24992209|PMID:25741868|PMID:26497376|PMID:28181551|PMID:28492532|PMID:29785639|PMID:31213501|PMID:31456290|PMID:31589614|PMID:31964843|PMID:34426522|PMID:36819107
Only show annotations with direct experimental evidence (0 objects hidden)
Cygb Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CYGB mRNA] CTD PMID:31150632 Cygb Rat (-)-epigallocatechin 3-gallate decreases expression ISO RGD:1345183 6480464 epigallocatechin gallate results in decreased expression of CYGB mRNA CTD PMID:20706672 Cygb Rat 17alpha-ethynylestradiol increases expression ISO RGD:733634 6480464 Ethinyl Estradiol results in increased expression of CYGB mRNA CTD PMID:17942748 Cygb Rat 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CYGB mRNA CTD PMID:17557909 Cygb Rat 17alpha-ethynylestradiol multiple interactions ISO RGD:733634 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CYGB mRNA CTD PMID:17942748 Cygb Rat 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 estradiol 3-benzoate promotes the reaction [Thioacetamide results in increased expression of CYGB mRNA] CTD PMID:15716488 Cygb Rat 2,2',5,5'-tetrachlorobiphenyl increases expression ISO RGD:1345183 6480464 2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of CYGB mRNA CTD PMID:36804509 Cygb Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733634 6480464 Tetrachlorodibenzodioxin results in increased expression of CYGB mRNA CTD PMID:19933214|PMID:28213091 Cygb Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYGB mRNA CTD PMID:34747641 Cygb Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1345183 6480464 Tetrachlorodibenzodioxin results in increased expression of CYGB mRNA CTD PMID:20106945|PMID:21632981 Cygb Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733634 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CYGB mRNA CTD PMID:17942748 Cygb Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1345183 6480464 2,2',4,4',5-brominated diphenyl ether results in increased expression of CYGB mRNA CTD PMID:26705709 Cygb Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO RGD:733634 6480464 2,2',4,4',5-brominated diphenyl ether affects the expression of CYGB mRNA CTD PMID:38648751 Cygb Rat 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYGB mRNA CTD PMID:32119087 Cygb Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of CYGB mRNA; alpha-Chlorohydrin results in increased expression of CYGB more ... CTD PMID:28522335|PMID:34915118 Cygb Rat 4,4'-sulfonyldiphenol increases expression ISO RGD:733634 6480464 bisphenol S results in increased expression of CYGB mRNA CTD PMID:30951980|PMID:39298647 Cygb Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Cygb Rat 4,4'-sulfonyldiphenol increases methylation ISO RGD:733634 6480464 bisphenol S results in increased methylation of CYGB exon CTD PMID:33297965 Cygb Rat 4-hydroxyphenyl retinamide increases expression ISO RGD:733634 6480464 Fenretinide results in increased expression of CYGB mRNA CTD PMID:28973697 Cygb Rat 5-aza-2'-deoxycytidine increases expression ISO RGD:1345183 6480464 Decitabine results in increased expression of CYGB mRNA CTD PMID:25781201 Cygb Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of CYGB mRNA CTD PMID:31881176 Cygb Rat actinomycin D multiple interactions ISO RGD:1345183 6480464 Dactinomycin inhibits the reaction [2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole results in increased expression of CYGB mRNA] CTD PMID:25781201 Cygb Rat aflatoxin B1 affects expression ISO RGD:1345183 6480464 Aflatoxin B1 affects the expression of CYGB protein CTD PMID:20106945 Cygb Rat aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CYGB mRNA CTD PMID:33354967 Cygb Rat aflatoxin B1 increases expression ISO RGD:1345183 6480464 Aflatoxin B1 results in increased expression of CYGB mRNA CTD PMID:21632981|PMID:21641981 Cygb Rat aldehydo-D-glucose decreases expression ISO RGD:1345183 6480464 Glucose results in decreased expression of CYGB mRNA CTD PMID:32942007 Cygb Rat all-trans-retinoic acid decreases expression ISO RGD:1345183 6480464 Tretinoin results in decreased expression of CYGB mRNA CTD PMID:23724009 Cygb Rat alpha-naphthoflavone multiple interactions ISO RGD:1345183 6480464 alpha-naphthoflavone inhibits the reaction [2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole results in increased expression of CYGB mRNA] CTD PMID:25781201 Cygb Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CYGB mRNA CTD PMID:35163327 Cygb Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYGB mRNA CTD PMID:16483693 Cygb Rat anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1345183 6480464 pyrazolanthrone inhibits the reaction [2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole results in increased expression of CYGB mRNA] CTD PMID:25781201 Cygb Rat arachidonic acid multiple interactions EXP 6480464 CYGB protein inhibits the reaction [[ferric nitrilotriacetate co-treated with Arachidonic Acid] results in increased expression more ... CTD PMID:16581302 Cygb Rat arsenous acid multiple interactions ISO RGD:1345183 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CYGB protein] CTD PMID:26598702 Cygb Rat benzo[a]pyrene increases expression ISO RGD:1345183 6480464 Benzo(a)pyrene results in increased expression of CYGB mRNA CTD PMID:20064835|PMID:20106945|PMID:21632981|PMID:21871943|PMID:22316170|PMID:35870112 Cygb Rat benzo[a]pyrene increases methylation ISO RGD:1345183 6480464 Benzo(a)pyrene results in increased methylation of CYGB promoter CTD PMID:27901495 Cygb Rat Benzo[ghi]perylene increases expression ISO RGD:733634 6480464 1,12-benzoperylene results in increased expression of CYGB mRNA CTD PMID:26377693 Cygb Rat beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYGB mRNA CTD PMID:18164116 Cygb Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYGB mRNA CTD PMID:25181051 Cygb Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Cygb Rat bisphenol A decreases expression ISO RGD:1345183 6480464 bisphenol A results in decreased expression of CYGB mRNA CTD PMID:31715268 Cygb Rat bisphenol A affects expression ISO RGD:1345183 6480464 bisphenol A affects the expression of CYGB mRNA CTD PMID:30903817 Cygb Rat bisphenol A increases expression ISO RGD:733634 6480464 bisphenol A results in increased expression of CYGB mRNA CTD PMID:30951980|PMID:32156529 Cygb Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYGB mRNA CTD PMID:28721559 Cygb Rat bisphenol A increases expression ISO RGD:1345183 6480464 bisphenol A results in increased expression of CYGB mRNA CTD PMID:27685785 Cygb Rat bisphenol F increases expression ISO RGD:733634 6480464 bisphenol F results in increased expression of CYGB mRNA CTD PMID:30951980 Cygb Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Cygb Rat butan-1-ol multiple interactions ISO RGD:1345183 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic more ... CTD PMID:29432896 Cygb Rat cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CYGB mRNA CTD PMID:33453195 Cygb Rat cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of CYGB mRNA CTD PMID:25993096 Cygb Rat cadmium sulfide increases expression ISO RGD:1345183 6480464 cadmium sulfide results in increased expression of CYGB mRNA CTD PMID:27866839 Cygb Rat cantharidin decreases expression ISO RGD:733634 6480464 Cantharidin results in decreased expression of CYGB mRNA CTD PMID:36907384 Cygb Rat carbon nanotube decreases expression ISO RGD:1345183 6480464 Nanotubes, Carbon results in decreased expression of CYGB mRNA CTD PMID:24389112 Cygb Rat cerium trichloride multiple interactions ISO RGD:1345183 6480464 [cerous chloride co-treated with lanthanum chloride] results in increased expression of CYGB mRNA CTD PMID:28954213 Cygb Rat cerium trichloride affects expression ISO RGD:1345183 6480464 cerous chloride affects the expression of CYGB mRNA CTD PMID:28954213 Cygb Rat chlorogenic acid decreases expression ISO RGD:1345183 6480464 Chlorogenic Acid results in decreased expression of CYGB mRNA CTD PMID:20706672 Cygb Rat chloropicrin decreases expression ISO RGD:1345183 6480464 chloropicrin results in decreased expression of CYGB mRNA CTD PMID:26352163 Cygb Rat chlorpyrifos increases expression ISO RGD:733634 6480464 Chlorpyrifos results in increased expression of CYGB mRNA CTD PMID:37019170 Cygb Rat cisplatin multiple interactions EXP 6480464 7-hydroxycoumarin inhibits the reaction [Cisplatin results in decreased expression of CYGB protein] CTD PMID:33522649 Cygb Rat cisplatin increases expression ISO RGD:1345183 6480464 Cisplatin results in increased expression of CYGB mRNA CTD PMID:27392435 Cygb Rat cisplatin multiple interactions ISO RGD:1345183 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CYGB mRNA CTD PMID:27392435 Cygb Rat cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CYGB protein CTD PMID:33522649 Cygb Rat cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of CYGB protein CTD PMID:25100957 Cygb Rat cyclosporin A decreases expression ISO RGD:1345183 6480464 Cyclosporine results in decreased expression of CYGB mRNA CTD PMID:25562108 Cygb Rat cyfluthrin decreases expression ISO RGD:1345183 6480464 cyfluthrin results in decreased expression of CYGB mRNA CTD PMID:31330490 Cygb Rat cypermethrin increases expression ISO RGD:733634 6480464 cypermethrin results in increased expression of CYGB mRNA CTD PMID:21142847 Cygb Rat D-glucose decreases expression ISO RGD:1345183 6480464 Glucose results in decreased expression of CYGB mRNA CTD PMID:32942007 Cygb Rat dextran sulfate decreases expression ISO RGD:733634 6480464 Dextran Sulfate results in decreased expression of CYGB protein CTD PMID:35362542 Cygb Rat dextran sulfate multiple interactions ISO RGD:733634 6480464 evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of CYGB protein] CTD PMID:35362542 Cygb Rat diarsenic trioxide multiple interactions ISO RGD:1345183 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CYGB protein] CTD PMID:26598702 Cygb Rat dimethylarsinous acid decreases expression ISO RGD:1345183 6480464 dimethylarsinous acid results in decreased expression of CYGB mRNA CTD PMID:23487506 Cygb Rat dioxygen increases expression ISO RGD:1345183 6480464 Oxygen deficiency results in increased expression of CYGB mRNA CTD PMID:35883890 Cygb Rat diuron decreases expression EXP 6480464 Diuron results in decreased expression of CYGB mRNA CTD PMID:25152437 Cygb Rat dorsomorphin multiple interactions ISO RGD:1345183 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Cygb Rat doxorubicin decreases expression ISO RGD:1345183 6480464 Doxorubicin results in decreased expression of CYGB mRNA CTD PMID:29803840 Cygb Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CYGB mRNA CTD PMID:29391264 Cygb Rat epalrestat increases expression ISO RGD:733634 6480464 epalrestat results in increased expression of CYGB mRNA; epalrestat results in increased expression of CYGB more ... CTD PMID:28204799 Cygb Rat epoxiconazole decreases expression ISO RGD:733634 6480464 epoxiconazole results in decreased expression of CYGB mRNA CTD PMID:35436446 Cygb Rat ethanol multiple interactions ISO RGD:733634 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CYGB mRNA CTD PMID:30517762 Cygb Rat ethanol increases expression ISO RGD:733634 6480464 Ethanol results in increased expression of CYGB mRNA CTD PMID:30319688 Cygb Rat ethanol multiple interactions ISO RGD:1345183 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic more ... CTD PMID:29432896 Cygb Rat ethyl methanesulfonate increases expression ISO RGD:1345183 6480464 Ethyl Methanesulfonate results in increased expression of CYGB mRNA CTD PMID:23649840 Cygb Rat ethylparaben increases expression ISO RGD:1345183 6480464 ethyl-p-hydroxybenzoate results in increased expression of CYGB mRNA CTD PMID:37690743 Cygb Rat EUK-134 multiple interactions ISO RGD:1345183 6480464 EUK-134 inhibits the reaction [2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole results in increased expression of CYGB mRNA] CTD PMID:25781201 Cygb Rat Evodiamine multiple interactions ISO RGD:733634 6480464 evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of CYGB protein] CTD PMID:35362542 Cygb Rat fenthion increases expression ISO RGD:733634 6480464 Fenthion results in increased expression of CYGB mRNA CTD PMID:34813904 Cygb Rat flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of CYGB mRNA CTD PMID:18035473 Cygb Rat furan increases expression EXP 6480464 furan results in increased expression of CYGB mRNA CTD PMID:27387713 Cygb Rat genistein decreases expression ISO RGD:1345183 6480464 Genistein results in decreased expression of CYGB mRNA CTD PMID:20706672 Cygb Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CYGB mRNA; Gentamicins results in increased expression of CYGB more ... CTD PMID:21081137|PMID:22061828|PMID:33387578 Cygb Rat glucose decreases expression ISO RGD:1345183 6480464 Glucose results in decreased expression of CYGB mRNA CTD PMID:32942007 Cygb Rat hydrogen peroxide increases metabolic processing EXP 6480464 CYGB protein results in increased metabolism of Hydrogen Peroxide CTD PMID:11320098 Cygb Rat inulin multiple interactions ISO RGD:733634 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CYGB mRNA CTD PMID:36331819 Cygb Rat iron(III) nitrilotriacetate multiple interactions EXP 6480464 CYGB protein inhibits the reaction [[ferric nitrilotriacetate co-treated with Arachidonic Acid] results in increased expression more ... CTD PMID:16581302 Cygb Rat isobutanol multiple interactions ISO RGD:1345183 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic more ... CTD PMID:29432896 Cygb Rat L-cysteine multiple interactions EXP 6480464 Cysteine inhibits the reaction [Thioacetamide results in increased expression of CYGB protein] CTD PMID:15158331 Cygb Rat L-methionine multiple interactions EXP 6480464 Methionine inhibits the reaction [Thioacetamide results in increased expression of CYGB protein] CTD PMID:15158331 Cygb Rat lanthanum trichloride multiple interactions ISO RGD:1345183 6480464 [cerous chloride co-treated with lanthanum chloride] results in increased expression of CYGB mRNA CTD PMID:28954213 Cygb Rat lanthanum trichloride affects expression ISO RGD:1345183 6480464 lanthanum chloride affects the expression of CYGB mRNA CTD PMID:28954213 Cygb Rat lead(0) affects expression ISO RGD:1345183 6480464 Lead affects the expression of CYGB mRNA CTD PMID:28903495 Cygb Rat Licochalcone B decreases expression ISO RGD:1345183 6480464 licochalcone B results in decreased expression of CYGB mRNA CTD PMID:33647349 Cygb Rat linoleic acid hydroperoxide increases metabolic processing EXP 6480464 CYGB protein results in increased metabolism of linoleic acid hydroperoxide CTD PMID:11320098 Cygb Rat lycopene increases expression EXP 6480464 Lycopene results in increased expression of CYGB mRNA CTD PMID:38444079 Cygb Rat methidathion increases expression ISO RGD:733634 6480464 methidathion results in increased expression of CYGB mRNA CTD PMID:34813904 Cygb Rat microcystin-LR increases expression ISO RGD:733634 6480464 cyanoginosin LR results in increased expression of CYGB mRNA CTD PMID:37342990 Cygb Rat N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of CYGB mRNA CTD PMID:28659758 Cygb Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYGB mRNA; [Diethylnitrosamine co-treated with Thioacetamide] more ... CTD PMID:18164116|PMID:28943392 Cygb Rat nickel sulfate decreases expression ISO RGD:1345183 6480464 nickel sulfate results in decreased expression of CYGB mRNA CTD PMID:22714537 Cygb Rat ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of CYGB mRNA CTD PMID:23358140 Cygb Rat okadaic acid decreases expression ISO RGD:1345183 6480464 Okadaic Acid results in decreased expression of CYGB mRNA CTD PMID:38832940 Cygb Rat Osajin decreases expression ISO RGD:1345183 6480464 osajin results in decreased expression of CYGB mRNA CTD PMID:20706672 Cygb Rat paracetamol affects expression ISO RGD:733634 6480464 Acetaminophen affects the expression of CYGB mRNA CTD PMID:17562736 Cygb Rat paracetamol decreases expression ISO RGD:1345183 6480464 Acetaminophen results in decreased expression of CYGB mRNA CTD PMID:29067470 Cygb Rat paracetamol increases expression ISO RGD:1345183 6480464 Acetaminophen results in increased expression of CYGB mRNA CTD PMID:22230336 Cygb Rat paraquat increases expression EXP 6480464 Paraquat results in increased expression of CYGB mRNA CTD PMID:20388547 Cygb Rat perfluorononanoic acid decreases expression ISO RGD:1345183 6480464 perfluoro-n-nonanoic acid results in decreased expression of CYGB mRNA CTD PMID:32588087 Cygb Rat perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:733634 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CYGB mRNA CTD PMID:36331819 Cygb Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CYGB mRNA CTD PMID:35163327 Cygb Rat permethrin multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of CYGB mRNA CTD PMID:28659758 Cygb Rat Pomiferin decreases expression ISO RGD:1345183 6480464 pomiferin results in decreased expression of CYGB mRNA CTD PMID:20706672 Cygb Rat puerarin decreases expression ISO RGD:1345183 6480464 puerarin results in decreased expression of CYGB mRNA CTD PMID:20706672 Cygb Rat Pyridostigmine bromide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of CYGB mRNA CTD PMID:28659758 Cygb Rat quercetin increases expression ISO RGD:1345183 6480464 Quercetin results in increased expression of CYGB mRNA CTD PMID:21632981 Cygb Rat quinolin-8-ol increases expression ISO RGD:1345183 6480464 Oxyquinoline results in increased expression of CYGB mRNA CTD PMID:21632981 Cygb Rat resveratrol decreases expression ISO RGD:1345183 6480464 resveratrol results in decreased expression of CYGB mRNA CTD PMID:20706672 Cygb Rat Rosavin decreases expression ISO RGD:1345183 6480464 rosavin results in decreased expression of CYGB mRNA CTD PMID:20706672 Cygb Rat SB 431542 multiple interactions ISO RGD:1345183 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Cygb Rat silver atom decreases expression ISO RGD:733634 6480464 Silver results in decreased expression of CYGB mRNA CTD PMID:19429238 Cygb Rat silver(0) decreases expression ISO RGD:733634 6480464 Silver results in decreased expression of CYGB mRNA CTD PMID:19429238 Cygb Rat sodium arsenite increases expression ISO RGD:1345183 6480464 sodium arsenite results in increased expression of CYGB mRNA CTD PMID:28229933 Cygb Rat sodium arsenite decreases expression ISO RGD:733634 6480464 sodium arsenite results in decreased expression of CYGB mRNA CTD PMID:36209798 Cygb Rat sodium fluoride increases expression ISO RGD:733634 6480464 Sodium Fluoride results in increased expression of CYGB protein CTD PMID:28918527 Cygb Rat sunitinib decreases expression ISO RGD:1345183 6480464 Sunitinib results in decreased expression of CYGB mRNA CTD PMID:31533062 Cygb Rat tert-butyl hydroperoxide increases expression ISO RGD:1345183 6480464 tert-Butylhydroperoxide results in increased expression of CYGB mRNA CTD PMID:27509014 Cygb Rat tetrachloromethane multiple interactions EXP 6480464 CYGB protein inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]; CYGB more ... CTD PMID:16581302|PMID:31150632 Cygb Rat tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CYGB mRNA CTD PMID:31150632 Cygb Rat tetrachloromethane multiple interactions ISO RGD:733634 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CYGB mRNA CTD PMID:30517762 Cygb Rat thapsigargin decreases expression ISO RGD:1345183 6480464 Thapsigargin results in decreased expression of CYGB mRNA CTD PMID:22378314 Cygb Rat thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CYGB mRNA; Cysteine inhibits the reaction more ... CTD PMID:15158331|PMID:15288473|PMID:15716488|PMID:17180598|PMID:28943392 Cygb Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CYGB mRNA; Thioacetamide results in increased expression of CYGB more ... CTD PMID:11320098|PMID:15158331|PMID:15288473|PMID:15716488|PMID:17180598|PMID:23411599|PMID:34492290 Cygb Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CYGB mRNA CTD PMID:33387578 Cygb Rat triclosan increases expression ISO RGD:1345183 6480464 Triclosan results in increased expression of CYGB mRNA CTD PMID:30510588 Cygb Rat tunicamycin decreases expression ISO RGD:1345183 6480464 Tunicamycin results in decreased expression of CYGB mRNA CTD PMID:22378314 Cygb Rat umbelliferone multiple interactions EXP 6480464 7-hydroxycoumarin inhibits the reaction [Cisplatin results in decreased expression of CYGB protein] CTD PMID:33522649 Cygb Rat umbelliferone increases expression EXP 6480464 7-hydroxycoumarin results in increased expression of CYGB protein CTD PMID:33522649 Cygb Rat urethane decreases expression ISO RGD:1345183 6480464 Urethane results in decreased expression of CYGB mRNA CTD PMID:28818685 Cygb Rat valproic acid increases expression ISO RGD:733634 6480464 Valproic Acid results in increased expression of CYGB mRNA CTD PMID:21427059 Cygb Rat valproic acid multiple interactions ISO RGD:1345183 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Cygb Rat valproic acid increases expression ISO RGD:1345183 6480464 Valproic Acid results in increased expression of CYGB mRNA CTD PMID:26272509 Cygb Rat valproic acid increases methylation ISO RGD:1345183 6480464 Valproic Acid results in increased methylation of CYGB gene CTD PMID:29154799 Cygb Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CYGB mRNA CTD PMID:23034163
(+)-schisandrin B (EXP) (-)-epigallocatechin 3-gallate (ISO) 17alpha-ethynylestradiol (EXP,ISO) 17beta-estradiol 3-benzoate (EXP) 2,2',5,5'-tetrachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 3,3',4,4',5-pentachlorobiphenyl (EXP) 3-chloropropane-1,2-diol (EXP) 4,4'-sulfonyldiphenol (EXP,ISO) 4-hydroxyphenyl retinamide (ISO) 5-aza-2'-deoxycytidine (ISO) acetamide (EXP) actinomycin D (ISO) aflatoxin B1 (EXP,ISO) aldehydo-D-glucose (ISO) all-trans-retinoic acid (ISO) alpha-naphthoflavone (ISO) alpha-Zearalanol (EXP) ammonium chloride (EXP) anthra[1,9-cd]pyrazol-6(2H)-one (ISO) arachidonic acid (EXP) arsenous acid (ISO) benzo[a]pyrene (ISO) Benzo[ghi]perylene (ISO) beta-naphthoflavone (EXP) bisphenol A (EXP,ISO) bisphenol F (EXP,ISO) butan-1-ol (ISO) cadmium dichloride (EXP) cadmium sulfide (ISO) cantharidin (ISO) carbon nanotube (ISO) cerium trichloride (ISO) chlorogenic acid (ISO) chloropicrin (ISO) chlorpyrifos (ISO) cisplatin (EXP,ISO) cocaine (EXP) cyclosporin A (ISO) cyfluthrin (ISO) cypermethrin (ISO) D-glucose (ISO) dextran sulfate (ISO) diarsenic trioxide (ISO) dimethylarsinous acid (ISO) dioxygen (ISO) diuron (EXP) dorsomorphin (ISO) doxorubicin (ISO) endosulfan (EXP) epalrestat (ISO) epoxiconazole (ISO) ethanol (ISO) ethyl methanesulfonate (ISO) ethylparaben (ISO) EUK-134 (ISO) Evodiamine (ISO) fenthion (ISO) flavonoids (EXP) furan (EXP) genistein (ISO) gentamycin (EXP) glucose (ISO) hydrogen peroxide (EXP) inulin (ISO) iron(III) nitrilotriacetate (EXP) isobutanol (ISO) L-cysteine (EXP) L-methionine (EXP) lanthanum trichloride (ISO) lead(0) (ISO) Licochalcone B (ISO) linoleic acid hydroperoxide (EXP) lycopene (EXP) methidathion (ISO) microcystin-LR (ISO) N,N-diethyl-m-toluamide (EXP) N-nitrosodiethylamine (EXP) nickel sulfate (ISO) ochratoxin A (EXP) okadaic acid (ISO) Osajin (ISO) paracetamol (ISO) paraquat (EXP) perfluorononanoic acid (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (EXP) permethrin (EXP) Pomiferin (ISO) puerarin (ISO) Pyridostigmine bromide (EXP) quercetin (ISO) quinolin-8-ol (ISO) resveratrol (ISO) Rosavin (ISO) SB 431542 (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) sodium fluoride (ISO) sunitinib (ISO) tert-butyl hydroperoxide (ISO) tetrachloromethane (EXP,ISO) thapsigargin (ISO) thioacetamide (EXP) trichloroethene (EXP) triclosan (ISO) tunicamycin (ISO) umbelliferone (EXP) urethane (ISO) valproic acid (ISO) vinclozolin (EXP)
Molecular Function
carbon monoxide binding (IEA,ISO) catalase activity (IDA) fatty acid peroxidase activity (IDA) heme binding (IBA,IDA,IEA) iron ion binding (IEA) metal ion binding (IEA) nitric oxide dioxygenase activity, heme protein as donor (IDA,IEA,ISO) nitrite reductase activity (IEA,ISO,ISS) oxidoreductase activity (IBA,IEA) oxygen binding (IEA,ISO) peroxidase activity (IDA) protein binding (ISO) superoxide dismutase activity (IEA,ISO,ISS)
1.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
2.
Characterization of a stellate cell activation-associated protein (STAP) with peroxidase activity found in rat hepatic stellate cells.
Kawada N, etal., J Biol Chem 2001 Jul 6;276(27):25318-23.
3.
Cytoglobin regulates blood pressure and vascular tone through nitric oxide metabolism in the vascular wall.
Liu X, etal., Nat Commun. 2017 Apr 10;8:14807. doi: 10.1038/ncomms14807.
4.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
5.
Cytoglobin, a novel globin, plays an antifibrotic role in the kidney.
Mimura I, etal., Am J Physiol Renal Physiol. 2010 Nov;299(5):F1120-33. doi: 10.1152/ajprenal.00145.2010. Epub 2010 Aug 18.
6.
Cytoglobin/STAP, its unique localization in splanchnic fibroblast-like cells and function in organ fibrogenesis.
Nakatani K, etal., Lab Invest. 2004 Jan;84(1):91-101.
7.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
8.
GOA pipeline
RGD automated data pipeline
9.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
10.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
11.
Cytoglobin is a respiratory protein in connective tissue and neurons, which is up-regulated by hypoxia.
Schmidt M, etal., J Biol Chem. 2004 Feb 27;279(9):8063-9. Epub 2003 Dec 3.
12.
Cytoglobin overexpression protects against damage-induced fibrosis.
Xu R, etal., Mol Ther. 2006 Jun;13(6):1093-100. Epub 2006 Apr 3.
Cygb (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 102,376,506 - 102,386,272 (-) NCBI GRCr8 mRatBN7.2 10 101,877,675 - 101,887,442 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 101,877,676 - 101,887,442 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 106,934,815 - 106,944,558 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 106,397,907 - 106,407,650 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 101,798,546 - 101,808,312 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 105,618,325 - 105,628,091 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 105,618,326 - 105,628,091 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 105,280,904 - 105,290,670 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 106,759,885 - 106,769,651 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 106,774,389 - 106,784,155 (-) NCBI Celera 10 100,448,536 - 100,458,302 (-) NCBI Celera Cytogenetic Map 10 q32.2 NCBI
CYGB (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 17 76,527,356 - 76,551,193 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 17 76,527,356 - 76,551,175 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 17 74,523,438 - 74,533,791 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 17 72,035,035 - 72,045,377 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 17 72,035,034 - 72,045,377 NCBI Celera 17 71,115,779 - 71,126,119 (-) NCBI Celera Cytogenetic Map 17 q25.1 NCBI HuRef 17 69,951,063 - 69,961,627 (-) NCBI HuRef CHM1_1 17 74,588,377 - 74,598,946 (-) NCBI CHM1_1 T2T-CHM13v2.0 17 77,424,099 - 77,449,394 (-) NCBI T2T-CHM13v2.0
Cygb (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 116,536,421 - 116,544,887 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 116,536,421 - 116,545,139 (-) Ensembl GRCm39 Ensembl GRCm38 11 116,645,595 - 116,654,504 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 116,645,595 - 116,654,313 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 116,506,909 - 116,515,627 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 116,461,685 - 116,470,403 (-) NCBI MGSCv36 mm8 Celera 11 128,416,859 - 128,425,516 (-) NCBI Celera Cytogenetic Map 11 E2 NCBI cM Map 11 81.45 NCBI
Cygb (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955506 5,766,006 - 5,775,784 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955506 5,766,006 - 5,775,722 (+) NCBI ChiLan1.0 ChiLan1.0
CYGB (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 19 92,570,565 - 92,601,134 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 17 97,395,777 - 97,406,085 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 17 70,475,651 - 70,485,987 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 17 76,167,003 - 76,178,247 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 17 76,167,947 - 76,179,412 (-) Ensembl panpan1.1 panPan2
CYGB (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 9 4,191,114 - 4,201,438 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 9 4,184,959 - 4,200,164 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 9 4,872,569 - 4,881,413 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 9 4,867,061 - 4,877,257 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 9 4,867,055 - 4,875,983 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 9 4,892,392 - 4,901,203 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 9 5,012,299 - 5,021,092 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 9 5,093,431 - 5,102,251 (+) NCBI UU_Cfam_GSD_1.0
Cygb (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405602 4,798,176 - 4,809,539 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936594 1,604,710 - 1,613,783 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936594 1,602,436 - 1,613,783 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
CYGB (Sus scrofa - pig)
CYGB (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 16 45,140,130 - 45,151,068 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 16 45,140,284 - 45,151,082 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666077 15,877,603 - 15,891,518 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Cygb (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 218 Count of miRNA genes: 143 Interacting mature miRNAs: 181 Transcripts: ENSRNOT00000016067 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1354641 Bvd2 Brain ventricular dilatation QTL 2 6.36 0.001 brain ventricle morphology trait (VT:0000822) hydrocephalus severity score (CMO:0001881) 10 93223816 107057807 Rat 61449 Ciaa2 CIA Autoantibody QTL 2 7.1 blood autoantibody amount (VT:0003725) calculated serum anti-type 2 collagen antibody titer (CMO:0001279) 10 63221094 107211142 Rat 61325 Aia5 Adjuvant induced arthritis QTL 5 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1298078 Stresp5 Stress response QTL 5 2.99 0.00025 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 42045676 104670812 Rat 1549831 Bss6 Bone structure and strength QTL 6 4 lumbar vertebra strength trait (VT:0010574) vertebra ultimate force (CMO:0001678) 10 57576521 102576521 Rat 1579915 Bp280 Blood pressure QTL 280 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 90404397 107211142 Rat 2298548 Neuinf7 Neuroinflammation QTL 7 3.4 nervous system integrity trait (VT:0010566) spinal cord RT1-B protein level (CMO:0002132) 10 72224939 107211142 Rat 1302404 Cia27 Collagen induced arthritis QTL 27 2.6 0.0045 joint integrity trait (VT:0010548) experimental arthritis severity measurement (CMO:0001459) 10 76452683 107211142 Rat 2317754 Glom25 Glomerulus QTL 25 3.5 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 10 82685200 107211142 Rat 70171 Cari1 Carrageenan-induced inflammation QTL 1 4.9 0.0005 hypodermis integrity trait (VT:0010550) inflammatory exudate volume (CMO:0001429) 10 53797385 107211142 Rat 10450493 Bp382 Blood pressure QTL 382 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 94759759 107211142 Rat 1578672 Bmd16 Bone mineral density QTL 16 6.2 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 10 96703043 107057807 Rat 61354 Pia10 Pristane induced arthritis QTL 10 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2313103 Bss80 Bone structure and strength QTL 80 2 0.0001 tibia strength trait (VT:1000284) tibia midshaft endosteal cross-sectional area (CMO:0001716) 10 62057807 107057807 Rat 2293646 Bss25 Bone structure and strength QTL 25 10.96 0.0001 femur morphology trait (VT:0000559) femur cross-sectional area (CMO:0001661) 10 69738412 107211142 Rat 2303118 Mamtr7 Mammary tumor resistance QTL 7 0.003 mammary gland integrity trait (VT:0010552) mammary tumor growth rate (CMO:0000344) 10 9658275 104670812 Rat 2300172 Bmd57 Bone mineral density QTL 57 9.8 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 10 69738412 107211142 Rat 70193 Mcs7 Mammary carcinoma susceptibility QTL 7 2.38 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 10 72224939 107211142 Rat 2313105 Bss79 Bone structure and strength QTL 79 1.8 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 10 62057807 107057807 Rat 61363 Oia3 Oil induced arthritis QTL 3 0.001 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 87307617 107211142 Rat 2316949 Gluco60 Glucose level QTL 60 3.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 10 14487011 107057807 Rat 724530 Bp149 Blood pressure QTL 149 0.0001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 90627439 107211142 Rat 1300137 Bp186 Blood pressure QTL 186 3.57 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 10 90627439 107057807 Rat 2293663 Bss33 Bone structure and strength QTL 33 9.34 0.0001 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 10 69738412 107211142 Rat 1578663 Bss18 Bone structure and strength QTL 18 3.6 femur width (VT:1000666) femoral neck width (CMO:0001695) 10 96703043 107057807 Rat 7387312 Bw125 Body weight QTL 125 3 0.0047 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight (CMO:0000356) 10 64890616 107211142 Rat 2312672 Insul15 Insulin level QTL 15 0.01 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 10 57134272 102134272 Rat 12880384 Cm107 Cardiac mass QTL 107 0.001 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 90404397 107211142 Rat 12880385 Cm108 Cardiac mass QTL 108 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 90404397 107211142 Rat 2317029 Aia19 Adjuvant induced arthritis QTL 19 2.98 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 10 66978955 107211142 Rat 2303589 Bw87 Body weight QTL 87 2 body mass (VT:0001259) body weight (CMO:0000012) 10 81285008 107211142 Rat 12880396 Am13 Aortic mass QTL 13 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 10 90404397 107211142 Rat 12880398 Kidm67 Kidney mass QTL 67 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 10 90404397 107211142 Rat 61387 Bp1 Blood pressure QTL 1 5.1 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 10 51770177 107211142 Rat 2317039 Aia6 Adjuvant induced arthritis QTL 6 4.31 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 10 66978955 107211142 Rat 12880395 Cm109 Cardiac mass QTL 109 0.001 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 10 90404397 107211142 Rat 61396 Bp9 Blood pressure QTL 9 4.8 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 68420376 107211142 Rat 634320 Niddm49 Non-insulin dependent diabetes mellitus QTL 49 4.41 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 10 88539139 107211142 Rat 1331791 Cm31 Cardiac mass QTL 31 3.84606 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 29299504 107211142 Rat 10450498 Bp384 Blood pressure QTL 384 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 67750049 107211142 Rat 4889492 Pancm2 Pancreatic morphology QTL 2 3.2 pancreatic beta cell morphology trait (VT:0005217) ratio of insulin-positive cell area to total area of splenic region of pancreas (CMO:0001814) 10 76748906 107211142 Rat 6893366 Bw106 Body weight QTL 106 0.3 0.47 body mass (VT:0001259) body weight (CMO:0000012) 10 70199100 107211142 Rat 2293698 Bss43 Bone structure and strength QTL 43 5.33 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra cross-sectional area (CMO:0001689) 10 59209888 104209888 Rat 1576313 Pia25 Pristane induced arthritis QTL 25 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 96120911 104060283 Rat 631267 Cia20 Collagen induced arthritis QTL 20 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1576307 Cia28 Collagen induced arthritis QTL 28 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 96120911 104060283 Rat 1576308 Schws1 Schwannoma susceptibility QTL 1 0.0041 nervous system integrity trait (VT:0010566) percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) 10 40035094 102359817 Rat 631269 Cia22 Collagen induced arthritis QTL 22 8.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 631268 Cia21 Collagen induced arthritis QTL 21 3.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 14487011 104060283 Rat 631270 Cia23 Collagen induced arthritis QTL 23 3.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 2292438 Bp311 Blood pressure QTL 311 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 76246085 107211142 Rat 2312662 Slep8 Serum leptin concentration QTL 8 0.05 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 10 57134272 102134272 Rat 2292436 Bp310 Blood pressure QTL 310 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 94759759 107211142 Rat 1600367 Mcs15 Mammary carcinoma susceptibility QTL 15 4.5 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 10 85565469 103884409 Rat 631539 Oia6 Oil induced arthritis QTL 6 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 97010147 104670812 Rat 631538 Oia5 Oil induced arthritis QTL 5 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 87055121 107211142 Rat 61436 Cia5 Collagen induced arthritis QTL 5 4.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 91228102 104060283 Rat 1642980 Bp300 Blood pressure QTL 300 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 68383129 107211142 Rat 2312668 Scl65 Serum cholesterol level QTL 65 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 10 57134272 102134272 Rat
RH133332
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 101,877,700 - 101,877,883 (+) MAPPER mRatBN7.2 Rnor_6.0 10 105,618,351 - 105,618,533 NCBI Rnor6.0 Rnor_5.0 10 105,280,930 - 105,281,112 UniSTS Rnor5.0 RGSC_v3.4 10 106,759,911 - 106,760,093 UniSTS RGSC3.4 Celera 10 100,448,562 - 100,448,744 UniSTS Cytogenetic Map 10 q32.3 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000016067 ⟹ ENSRNOP00000016067
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 101,877,676 - 101,887,442 (-) Ensembl Rnor_6.0 Ensembl 10 105,618,326 - 105,628,091 (-) Ensembl
RefSeq Acc Id:
NM_130744 ⟹ NP_570100
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 102,376,506 - 102,386,272 (-) NCBI mRatBN7.2 10 101,877,675 - 101,887,442 (-) NCBI Rnor_6.0 10 105,618,325 - 105,628,091 (-) NCBI Rnor_5.0 10 105,280,904 - 105,290,670 (-) NCBI RGSC_v3.4 10 106,759,885 - 106,769,651 (-) RGD Celera 10 100,448,536 - 100,458,302 (-) RGD
Sequence:
CACAGACACACACACACACACACACACACACACACACACACACGCTCCCTCCCTCCGGCGCTCTACTCCGCGCCCGCCCGCCCGCTCGCCCGCCCGCCCGCCTCGCACGCACCGGCCTCGGCTCCCCG CGCCCGCCGCCGAGCGAAGCTGCTCTGGGATCGGAGCAGCTCATGGAGAAAGTGCCGGGCGACATGGAGATAGAGCGCAGGGAGAGGAACGAGGAGCTGTCCGAGGCGGAGAGGAAGGCGGTTCAGGC TACGTGGGCCCGGCTGTATGCCAACTGCGAGGACGTGGGGGTGGCCATCCTGGTGAGGTTCTTTGTGAACTTCCCGTCGGCCAAGCAGTACTTCAGCCAGTTTAAACACATGGAGGATCCGTTGGAGA TGGAGAGGAGTCCTCAGCTGCGGAAACATGCCTGCCGGGTCATGGGGGCCCTCAACACGGTCGTGGAGAACCTGCATGACCCAGACAAGGTATCCTCTGTGCTCGCGCTGGTTGGCAAGGCCCACGCC CTCAAGCACAAGGTGGAACCTATGTACTTTAAGATTCTCTCTGGGGTCATTCTGGACGTGATCGCCGAGGAGTTTGCCAATGACTTCCCCGTCGAGACGCAGAAAGCCTGGACCAAGCTGCGCGGTCT CATCTACAGCCATGTGACCGCGGCCTACAAGGAAGTGGGCTGGGTACAGCAGGTCCCCAACACCACCACCCTACCAGCCACACTGCCCTCTTCAGGGCCATAGGACCCCTCCCAGCTCCCCCCTCCCT GGCAGCACTTTGGGCAGAAGGCTGACTTCTGAAGACACTCCTTGACCTTCCATTTCTGGGTGCCAAGGAAGCTGGAGGAACCCCTGACTGGACTTCCCGAAAGGAGGCCTTCATCATGGCTGTGGTCT CCCACGTTACTGGGAGGTGGGGCTGGCTACCTGGATGCTGAATTTAGCAGAGGGGAACCCTTCTGCCTCGCAGCAGAGGGCACACCCTCCTTAGCTTTCACTGTCAAGAGAGGGACCTGGCATGTGGC CGGTGGGAAGCAAGGACAAGCCTTTGAGTCACTTCAGAAAGGAACTAGCCCTGCTTCACTCTGCCCTACCAGCATGCAGGTTCTCCTCACCATCTCTGAGCATTGCGCACACACACGTCTACCATATA CACAGATATATTCTATATACGAGCTCTATATAAATATATATACACACACACACGTACATATCTGTCGCGTGCACCTGCAGGCCCAGAAGCCTAGGCCTCGCACAGCTGTGGGAGACCCGGAAGAGTCC TGGCCGTACTTCAGGGCAGCTCTACCGGGAGCAGGGAGAAAGCTTGCAACAGCACGAGAGGGCGGGGCCGGGTGGGAGAGTCGGGGTGACTCAGCTCACCCCGCACAGCTCAGTGCCCTGCAATCTTC CCCTTCCGCCCCCCAAAAGAGAACACTTGGTTTGCCCGGTGTCGGGGCGCACACCTGTAATCCCCGAGTTTGGGACGCAGAGGAAGGACAATCTTTGCAAGTCTGAGGTCAGGTGGTCTACACTTGGT CTCCATCTTGGTGAGTTTCCGGCTAGCTGGGGTCGACTCAGGGAGACCCCGTGTCAAACAAAACAAGAAGCGAAGAGAAGATCTGGCTCCCCTCCCCTCCCCAAGGGTTTGCCCGACTGACTTGCTCC GGAAAGGGGCACACCGAGAATTCAGGAGACCCCAGTGGGGTGCTGGCCAGTGTAGGTGTCCGGCGTTTGGGGGTGGGGTGAGGGGCAGCTTCAGCGTGGAGCCCTAGAATGTCAGCCTCACCCGCTCA CTTCAGACAGCAGCCAGGCCACAGGACCAGGGGCCATACTCAAACCCCTCAGCAGAGACCAGGGCGCCTCTCTCCTGCCCTCCTCGGGGCCACCTGCCCATCCTCTCCAACTAGTCTCCGTAACATTC GCTGGGGACCCCGTGTGTACCCCTTGGTCACGTGTACTGTCCTGGAGGACGTCTTACTGCTGTGGCTACCGTGCCTGCGTCCCCTCTGGTCCCACCCTCACGCAGCCTTCCTGTAACTGCCTGTCTTT TTGTAGTTTCTGATGTTTGTAACCAGACCCAGCTGTGTCATTAAACAGGTCTGTTCTTCCTGTAAAAAAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
NP_570100 ⟸ NM_130744
- UniProtKB:
Q921A4 (UniProtKB/Swiss-Prot), A0A1K0GY57 (UniProtKB/TrEMBL), A6HKY0 (UniProtKB/TrEMBL)
- Sequence:
MEKVPGDMEIERRERNEELSEAERKAVQATWARLYANCEDVGVAILVRFFVNFPSAKQYFSQFKHMEDPLEMERSPQLRKHACRVMGALNTVVENLHDPDKVSSVLALVGKAHALKHKVEPMYFKILS GVILDVIAEEFANDFPVETQKAWTKLRGLIYSHVTAAYKEVGWVQQVPNTTTLPATLPSSGP
hide sequence
Ensembl Acc Id:
ENSRNOP00000016067 ⟸ ENSRNOT00000016067
RGD ID: 13697920
Promoter ID: EPDNEW_R8445
Type: single initiation site
Name: Cygb_1
Description: cytoglobin
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 10 105,628,101 - 105,628,161 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2004-09-10
Cygb
cytoglobin
Staap
stellate cell activation associated protein
Symbol and Name updated
1299863
APPROVED
2002-06-10
Staap
stellate cell activation associated protein
Symbol and Name status set to approved
70586
APPROVED
Note Type
Note
Reference
gene_disease
increased expression in fibrotic liver tissues is induced by thioacetamide (TAA) administration; functions in the development of liver fibrosis
68672
gene_function
peroxidase that catabolizes hydrogen peroxide and lipid hydroperoxides
68672
gene_process
may play a role as an antifibrotic scavenger of peroxides in the liver
68672
gene_protein
190 amino acids
68672
gene_regulation
expression dramatically increased in fibrotic liver tissues induced by thioacetamide (TAA) administration
68672
gene_regulation
heavily up-regulated both in in vitro and in vivo activated stellate cells
68672